CD30 ligand

CD30 ligand Molekülinformation

Englischer Name	Tumor necrosis factor ligand superfamily member 8	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	0	Target-Alias	CD153，CD30LG，CD30 ligand，CD30-L，CD30L，Tumor Necrosis Factor (Ligand) Superfamily， Member 8，TNF Superfamily Member 8，Tumor Necrosis Factor Ligand Superfamily Member 8，TNLG3A，CD153 Antigen，Tumor Necrosis Factor Superfamily Member 8，Tumor Necrosis Factor Ligand 3A，CD30 Antigen Ligand
Höchste Forschungs- und Entwicklungsphase	Preclinical

Englischer Name	Tumor necrosis factor ligand superfamily member 8
Target-Alias	CD153，CD30LG，CD30 ligand，CD30-L，CD30L，Tumor Necrosis Factor (Ligand) Superfamily， Member 8，TNF Superfamily Member 8，Tumor Necrosis Factor Ligand Superfamily Member 8，TNLG3A，CD153 Antigen，Tumor Necrosis Factor Superfamily Member 8，Tumor Necrosis Factor Ligand 3A，CD30 Antigen Ligand
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	0
Höchste Forschungs- und Entwicklungsphase	Preclinical

CD30 ligand Produktliste

Attribut
Protein (2)
Produktbibliothek
Online (2)
Spezies
Human (2)
Etikett
Mouse IgG Fc Tag (1)His Tag (1)
Marker
Unconjugated (2)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
CDL-H524b	Human	HEK293	Human CD30 Ligand / TNFSF8 Protein, His Tag, low endotoxin (MALS verified)				In den Warenkorb legen
CDL-H525b	Human	HEK293	Human CD30 Ligand / TNFSF8 Protein, Mouse IgG2a Fc Tag, low endotoxin				In den Warenkorb legen

Gesamtmenge2

CD30 ligand Molekülhintergrund

CD30 ligand (CD30L) and CD30 are interacting cellsurface glycoproteins that are members of the tumour necrosis factor (TNF) and tumour necrosis factor receptor (TNFR) superfamilies. In humans, CD30L is expressed at high levels on activated T cells. There is conflicting evidence with regard to cell surface expression of CD30L on primary human B cells. An initial report of constitutive CD30L expression on peripheral blood B cells33 has not been substantiated.